Use of Pristinamycin for Infections by Gram-Positive Bacteria: Clinical Experience at an Australian Hospital

被引：20

作者：

Reid, A. B. ^{[1
]}

Daffy, J. R. ^{[1
]}

Stanley, P. ^{[1
]}

Buising, K. L. ^{[1
]}

机构：

[1] St Vincents Hosp, Infect Dis Unit, Melbourne, Vic 7000, Australia

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2010年 / 54卷 / 09期

关键词：

STAPHYLOCOCCUS-AUREUS MRSA; INVITRO ACTIVITY; MANAGEMENT; THERAPY;

D O I：

10.1128/AAC.00212-10

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Thirty-six patients were treated with pristinamycin for 46 different microbiological isolates between April 2007 and July 2009. Pathogens included 9 methicillin-resistant Staphylococcus aureus isolates, 13 methicillin-resistant coagulase negative staphylococci, and 9 vancomycin-resistant enterococci. Sites of infections included 12 osteomyelitis cases, 10 prosthetic joints, 4 other prostheses, and 1 epidural abscess. Five patients ceased treatment due to side effects. Ten patients were cured of their infections, and 21 patients had infections successfully suppressed.

引用

页码：3949 / 3952

页数：4

共 10 条

[1] ANTIBACTERIAL ACTIVITY OF LINCOMYCIN + PRISTINAMYCIN - COMPARISON WITH ERYTHROMYCIN [J].

BARBER, M ;

WATERWORTH, PM .

BRITISH MEDICAL JOURNAL, 1964, 2 (540) :603-&

[2] INVITRO ACTIVITY OF RP 59500, A NEW SEMISYNTHETIC STREPTOGRAMIN ANTIBIOTIC, AGAINST GRAM-POSITIVE BACTERIA [J].

BRUMFITT, W ;

HAMILTONMILLER, JMT ;

SHAH, S .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1992, 30 :29-37

[3] Oral streptogramins in the management of patients with methicillin-resistant Staphylococcus aureus (MRSA) infections [J].

Dancer, SJ ;

Robb, A ;

Crawford, A ;

Morrison, D .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 51 (03) :731-735

[4] EVOLUTION AND EPIDEMIOLOGY OF MLS RESISTANCE [J].

DUVAL, J .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1985, 16 :137-149

[5] COMPARATIVE INVITRO ACTIVITIES OF PRISTINAMYCIN AND OTHER ANTIMICROBIAL AGENTS AGAINST GENITAL PATHOGENS [J].

LEFEVRE, JC ;

BAURIAUD, R .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (12) :2152-2154

[6] COMPARATIVE INVITRO ACTIVITY OF ERYTHROMYCIN, VANCOMYCIN AND PRISTINAMYCIN [J].

MASKELL, JP ;

SEFTON, AM ;

YONG, J ;

CHI, SJ ;

WILLIAMS, JD .

INFECTION, 1988, 16 (06) :365-370

[7] Successful oral pristinamycin therapy for osteoarticular infections due to methicillin-resistant Staphylococcus aureus (MRSA) and other Staphylococcus spp. [J].

Ng, J ;

Gosbell, IB .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 55 (06) :1008-1012

[8]

PARIS JM, 1990, RECENT PROGR CHEM SY, P185

[9] Pristinamycin as adjunctive therapy in the management of Gram-positive multi-drug resistant organism (MDRO) osteoarticular infection [J].

Ruparelia, N. ;

Atkins, B. L. ;

Hemingway, J. ;

Berendt, A. R. ;

Byren, I. .

JOURNAL OF INFECTION, 2008, 57 (03) :191-197

[10] Linezolid: a review of safety and tolerability [J].

Vinh, Donald C. ;

Rubinstein, Ethan .

JOURNAL OF INFECTION, 2009, 59 :S59-S74

← 1 →